Price:
Rs. 6,150.00
Sample Type: PURE CULTURE
Fasting Not Requierd
Booking Procedure:
- Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
- Soft copy reports will be sent to your email address within 24 to 48 hours.
Frequently Asked Questions (FAQ's):
What does the AFB 2nd Line Drug Susceptibility Panel test include?
This Metropolis Healthcare test evaluates Mycobacterium tuberculosis against four major second-line anti-TB drugs—Kanamycin, Ethionamide, PAS, and Ofloxacin—to determine resistance patterns.
Why choose Metropolis Healthcare for second-line TB drug testing?
Metropolis Healthcare provides advanced mycobacteriology facilities, experienced microbiologists, stringent quality protocols, and highly accurate drug-resistance reporting for reliable TB management.
What sample type does Metropolis Healthcare require for this test?
A pure culture of Mycobacterium tuberculosis is needed. This allows Metropolis Healthcare to perform detailed second-line drug susceptibility analysis with precision.
Who should undergo this test at Metropolis Healthcare?
Patients diagnosed with MDR-TB, those not responding to first-line therapy, or individuals suspected of harboring second-line drug resistance should consider this test.
How does Metropolis Healthcare perform the susceptibility testing?
The pure culture is exposed to each second-line drug under controlled conditions. Metropolis Healthcare follows standardized, high-quality procedures to accurately determine sensitivity or resistance.
How long do results usually take?
Results typically take several days, as Metropolis Healthcare conducts careful incubation and interpretation to ensure reliable susceptibility findings.
How does this test help in TB treatment planning?
It identifies resistance to second-line drugs, which is crucial for designing effective treatment regimens for MDR-TB and difficult TB cases.
Is this test useful for monitoring treatment outcomes?
Yes. Metropolis Healthcare uses this test to help assess therapy effectiveness and guide medication adjustments when resistance is suspected during treatment.